1Life Healthcare, Inc.
If you purchased 1Life Healthcare, Inc. securities and would like to join the action, please click "Join This Action" below.
ONEM STOCK ALERT: HALPER SADEH LLP IS INVESTIGATING WHETHER THE SALE OF 1LIFE HEALTHCARE, INC. IS FAIR TO SHAREHOLDERS
July 21, 2022.
New York, New York—Halper Sadeh LLP, an investor rights law firm, is investigating whether the sale of 1Life Healthcare, Inc. (NASDAQ: ONEM) to Amazon.com, Inc. for $18.00 per share in cash is fair to 1Life shareholders.
The investigation concerns whether 1Life and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to, among other things: (1) obtain the best possible consideration for 1Life shareholders; (2) determine whether Amazon is underpaying for 1Life; and (3) disclose all material information necessary for 1Life shareholders to adequately assess and value the merger consideration. On behalf of 1Life shareholders, Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.
Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.